The Valley Desk

NCT00078312 · Interventional trial

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Overall registry status Completed

Phase 3

Conditions Narcolepsy, Shift-Work Sleep Disorder, Sleep Apnea Syndromes, Sleep Apnea, Obstructive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov